Beam Therapeutics Inc
BEAM
$24.27-1.58%
End of day · as of Sep 27, 2026, 6:01 PM ET
Mkt cap
$2.01B
EV/Sales
12.3
P/E ratio
N/A
FY2025 Revenue
$139.74M
EPS (TTM)
$-0.67
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-57.24%
Beta
2.08
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Latest reported BEAM revenue for 2025-12-31 was $139.7M. Net income was -$80.0M. Revenue was up 120.0% from 2024-12-31 to 2025-12-31. BEAM currently screens at market cap $2.01B.
Use this BEAM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BEAM income, balance, and cash tables.
Beam Therapeutics Inc (BEAM) is a biotechnology company in the Healthcare sector.
Latest cached Beam Therapeutics Inc (BEAM) revenue for Dec 31, 2025 was $139.7M. Net income was -$80.0M. Statements: https://lician.com/financials/beam
Beam Therapeutics Inc (BEAM) market capitalization is $2.01B on the latest cached snapshot.
Beam Therapeutics Inc (BEAM) cached previous close $24.66; day range $23.75 – $24.97; volume 1,179,274. Session quote: https://lician.com/quote/beam